Certificate of Advanced Studies in Lung cancer - second cohort (CASLu2)
24.03.2021 - 26.05.2022
APPLICATION CLOSED
POSTGRADUATE PROGRAMME
Block 2
28.03.2021 - 15.07.2021
CASLu2: Module 1: Epidemiology, prevention, biology & pathology of LC & other thoracic malignancies
Programme
28 March | ||
| Epidemiology Paolo Boffetta, US | ||
| Risk factors and environmental exposure Emma O'Dowd, UK | ||
| Primary prevention Emily Stone, AU | ||
| Screening John Field, UK | ||
| Proteogenomic Alterations in Lung Cancer Ramaswamy Govindan, US | ||
| Immuno-oncology from a biological perspective: Biological principles of tumor immunology Maries van den Broek, CH | ||
| Immuno-oncology from a biological perspective: Biomarkers from immuno-oncology Ming-Sound Tsao, CA | ||
| Molecular classification of lung cancer Martin Sos, DE | ||
| Methods of molecular diagnostics: Tissue based Erik Thunnissen, NL | ||
| Methods of molecular diagnostics: Nucleic-acid based Nicola Normanno, IT | ||
| Pathological classification of lung cancer: NSCLC & SCLC Alexander Haragan, UK | ||
| Epidemiology and pathological classification of rare thoracic malignancies Andrew Nicholson, UK | ||
| Cancer survivorship Dany Bell, UK | ||
Faculty
Dany Bell, Macmillan Cancer Support, Strategic Adviser Treatment, Medicines, Genomics Dept., London, UK
Paolo Boffetta, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, US
John Field, The University of Liverpool Cancer Research Centre, Roy Castle Lung Cancer Research Programme, Liverpool, UK
Ramaswamy Govindan, Washington University School of Medicine, Division of Oncology, St. Louis, MO, US
Alexander Haragan, Royal Liverpool University Hospital, Dept. of Pathology, Liverpool, UK
Andrew Nicholson, Royal Brompton Hospital, Histophatology Dept., London, UK
Nicola Normanno, ITN - IRCCS G. Pascale Foundation, Cell Biology and Biotherapy Unit, Napoli, IT
Emma O'Dowd, Nottingham City Hospital, Dept. of Epidemiology and Public Health, Nottingham, UK
Martin Sos, University Hospital Cologne, Molecular Pathology, Cologne, DE
Emily Stone, St. Vincent's Hospital, Dept. of Thoracic Medicine, Darlinghurst, AU
Erik Thunnissen, VUMC Amsterdam, Dept. of Pathology, Amsterdam, NL
Ming-Sound Tsao, Princess Margaret Cancer Centre, Ontario Cancer Institute, Toronto, CA
Maries van den Broek, Zurich, CH